A peptide is a short chain of amino acids — the exact same building blocks that make up proteins, just fewer of them strung together. The rough rule of thumb: a handful up to about fifty amino acids is a "peptide"; longer than that and biologists start calling it a "protein"1. That's really all the word means.
In plain terms: a peptide is a mini-protein — a small molecular message.
Why peptides are interesting to study
Your body already runs on peptides. Many of its own signalling molecules — the messages that tell tissues what to do — are peptides: insulin, GLP-1, ghrelin, GHRH, and dozens more. Because these natural signals are peptides, scientists can design synthetic peptides that copy or tweak them to interact with the same systems1. That's the entire logic behind the compounds this site describes: a lab-made peptide that mimics a natural signal can, in principle, switch the same biology on or off.
"Research compound" means what it says
Here's the honest framing most vendor pages avoid. Many of the peptides discussed in this scene are research compounds — studied in preclinical settings (animals and cells) and not approved as medicines for the uses people are curious about. That label isn't a legal fig leaf bolted on afterward; it's a description of where the evidence actually stands.
An educational reference tells you what a compound is and how it's studied — not how to use it. And a good one is blunt about the difference between "showed promise in rats" and "proven to work in humans."
The evidence runs from strong to almost none
The most important thing a beginner can learn is that "peptide" says nothing about how good the evidence is. It ranges wildly:
| Evidence level | What it means | Examples on this site |
|---|---|---|
| Approved medicine | Large human trials; regulator-approved | Semaglutide, tirzepatide, tesamorelin |
| Human/clinical data | Real human studies, but narrower or not a full approval | CJC-1295 (PK), sermorelin (Geref history) |
| Mostly preclinical | Encouraging animal/cell work; little or no human proof | BPC-157, TB-500, ipamorelin |
Two peptides can sit in the same conversation and be worlds apart in how well they're proven. Reading each honestly is the skill.
The main families covered here
- Growth-hormone secretagogues — peptides that prompt your own growth-hormone release, split into two sub-families by which receptor they use: GHRH analogs (CJC-1295, sermorelin, tesamorelin) and GHS/ghrelin agonists (ipamorelin, GHRP-6/2). Start with growth-hormone secretagogues explained.
- Recovery-research peptides — BPC-157 and TB-500, studied for tissue repair, mostly in animals.
- Incretin agonists (approved medicines, not research-only) — semaglutide and tirzepatide; see GLP-1 receptor agonists explained.
The practical skills are shared
Whatever the compound, the hands-on knowledge overlaps: reconstitution (mixing a freeze-dried powder with liquid), reading a syringe, and understanding half-life (how long a dose lasts). Those are the topics this site's tools and guides cover.
A note on regulation
Because many research peptides aren't approved drugs, their legal and pharmacy status is genuinely in motion. In 2023 the FDA flagged several of them on its 503A bulk-substances review list for compounding pharmacies, and that status has continued to shift since2. It's a moving picture worth checking rather than assuming. This site never discusses sourcing.
The short version
A research peptide is a short, lab-made amino-acid chain designed to interact with the body's own peptide-signalling systems. "Research compound" honestly means most are studied mainly in animals and cells, though a few are fully approved medicines — so the evidence behind any given peptide can be enormous or nearly empty. The one habit worth keeping: ask what the actual evidence is, and whether it's human or animal. This is an educational overview — no part of it is usage guidance, sourcing, or medical advice.